Category | Esk28 (NÂ =Â 41) | Esk56 (NÂ =Â 40) | Esk84 (NÂ =Â 41) | Placebo (NÂ =Â 80) |
---|---|---|---|---|
Baseline | ||||
 N | 41 | 40 | 41 | 80 |
 Mean (SD) | 38.4 (6.07) | 37.9 (5.41) | 35.9 (5.28) | 37.7 (5.65) |
 Median (Range) | 36.0 (28; 58) | 37.5 (29; 49) | 35.0 (28; 47) | 37.0 (29; 51) |
Day 28 | ||||
 N | 39 | 34 | 39 | 72 |
 Mean (SD) | 22.9 (12.46) | 23.6 (11.01) | 21.0 (11.24) | 22.4 (11.43) |
 Median (Range) | 24.0 (0; 55) | 22.0 (2; 47) | 19.0 (1; 43) | 21.5 (1; 46) |
Change from baseline to Day 28 (DB) | ||||
 N | 39 | 34 | 39 | 72 |
 Mean (SD) | - 15.2 (13.07) | - 14.5 (10.53) | - 15.1 (12.21) | - 15.3 (11.68) |
 Median (Range) | - 13.0 (− 52; 7) | - 15.0 (− 40; 5) | - 15.0 (− 44; 5) | - 13.0 (− 50; 4) |
MMRM analysisa | ||||
 Diff. of LS means (SE) (Esk minus Placebo) | - 1.0 (2.25) | 0.6 (2.33) | - 0.9 (2.26) |  |
 90% confidence interval on diffb | - 5.77; 3.70 | - 4.32; 5.47 | - 5.66; 3.83 |  |
 1-sided p-value (Esk minus Placebo)b | 0.475 | 0.504 | 0.482 |  |